June 5, 2024, 4:43 a.m. | Vineeth Dorna, D. Subhalingam, Keshav Kolluru, Shreshth Tuli, Mrityunjay Singh, Saurabh Singal, N. M. Anoop Krishnan, Sayan Ranu

cs.LG updates on arXiv.org arxiv.org

arXiv:2406.01650v1 Announce Type: cross
Abstract: 3D generative models have shown significant promise in structure-based drug design (SBDD), particularly in discovering ligands tailored to specific target binding sites. Existing algorithms often focus primarily on ligand-target binding, characterized by binding affinity. Moreover, models trained solely on target-ligand distribution may fall short in addressing the broader objectives of drug discovery, such as the development of novel ligands with desired properties like drug-likeness, and synthesizability, underscoring the multifaceted nature of the drug design process. …

abstract algorithms arxiv cs.ai cs.lg design distribution drug design focus generative generative models gradient ligands q-bio.bm type

Senior Data Engineer

@ Displate | Warsaw

Content Designer

@ Glean | Palo Alto, CA

IT&D Data Solution Architect

@ Reckitt | Hyderabad, Telangana, IN, N/A

Python Developer

@ Riskinsight Consulting | Hyderabad, Telangana, India

Technical Lead (Java/Node.js)

@ LivePerson | Hyderabad, Telangana, India (Remote)

Backend Engineer - Senior and Mid-Level - Sydney Hybrid or AU remote

@ Displayr | Sydney, New South Wales, Australia